ACT — AlzChem AG Cashflow Statement
0.000.00%
Last trade - 00:00- €1.04bn
- €1.03bn
- €554.23m
- 93
- 28
- 60
- 67
Annual cashflow statement for AlzChem AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 27.2 | 36.5 | 41.3 | 48.2 | 75.3 |
| Depreciation | |||||
| Non-Cash Items | 10.2 | 3.77 | -4.21 | 19.1 | 22.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.8 | -21.7 | -66.9 | -20.5 | -18.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 48.7 | 43 | -4.24 | 72.7 | 105 |
| Capital Expenditures | -28.8 | -28.5 | -29.1 | -20.6 | -43.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.003 | 0.056 | 0.557 | 0.009 | 12.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -28.8 | -28.5 | -28.5 | -20.5 | -31 |
| Financing Cash Flow Items | -0.171 | -0.171 | -0.171 | -0.171 | -0.171 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -11.7 | -23.6 | 33.6 | -49.2 | -24.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.06 | -8.83 | 0.958 | 2.64 | 49.7 |